Search the Newsreel

Pomona hospital upgrades its surgical robots

Pomona Valley Hospital Medical Center has upgraded its surgical robot system by acquiring three of the latest Intuitive da Vinci 5 surgical systems. This new fleet of technology offers improved resolution, more realistic 3D imaging, and applies significantly less force on tissue, benefiting patients …

Why STAAR Surgical (STAA) Is Getting Fresh Attention Now

AbCellera (ABCL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Chief Legal and Compliance Officer - Tryn Stimart President and Chief Executive Officer - Carl L. Hansen Chief Financial Officer - Andrew Booth Full Conference Call Transcript Operator: …

STAAR Surgical (NASDAQ:STAA) Releases Quarterly Earnings Results, Misses Estimates By $0.06 EPS

Sagicor Financial Q2 adj. EPS $0.25 beats $0.23 estimate

The Real Price of Intuitive Surgical Stock's Robotic Future

Satellogic (SATL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Founder and Chief Executive Officer - Emiliano Kargieman Chief Financial Officer - Rick Dunn Need a quote from a Motley Fool analyst? Email pr@fool.com Full Conference Call Transcript …

ADMA Biologics: The Earnings Reset Still Leaves More Upside (NASDAQ:ADMA)

Intuitive Surgical (ISRG) Beats On Q2 As Investors Ask If The Bull Case Is Priced In

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Intuitive Surgical (ISRG) shook investors after reporting strong Q2 2026 revenue and earnings that beat expectations, while revealing slower U.S. procedure growth and …

Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates

Staar Surgical (STAA) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to a loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

STAAR Surgical (NASDAQ:STAA) Delivers Strong Q2 CY2026 Numbers But Stock Drops

STAAR Surgical (NASDAQ:STAA) reported strong Q2 CY2026 results, with revenue up 111% year-on-year to $93.54 million, exceeding analyst expectations, and GAAP EPS of $0.16, beating estimates by 12.6%. Despite these positive numbers, the stock dropped 8% immediately after the announcement. The company's operating margin …

QuickLogic Corp Q2 2026: Revenue $5.48M, EPS ($0.05) — 10-Q Summary

QuickLogic Corp reported its second-quarter 2026 results, showing a significant increase in revenue to $5.48 million from $3.69 million in the prior year, driven by eFPGA IP licensing and professional services. The company's net loss narrowed to ($887K) and diluted EPS improved to ($0.05). …

QuickLogic (QUIK) boosts Q2 2026 revenue 49% as losses narrow sharply

QuickLogic (QUIK) reported significantly improved financial results for Q2 2026, with revenue from continuing operations increasing by 49% year-over-year to $5.5 million, primarily driven by eFPGA IP and professional services. The company's net loss from continuing operations sharply narrowed from $2.7 million to $0.9 …

STAAR Surgical Q2 2026 Earnings: China Rebound Restores Profitability

Charles Schwab Corp. (GIC) holder details planned and recent stock sales

A Charles Schwab Corp. shareholder, Thomas Axmacher, has filed a notice of intent to sell 952 shares of company common stock, valued at $36,918.56. The filing also reports a recent sale of 1,848 shares on August 6, 2026, for $71,332.80, and details prior equity …

GIC Housing Finance: FY27 తొలి త్రైమాసికంలో ₹10.08 కోట్ల లాభం; కొత్త చైర్మన్ నియామకం

Earnings Flash (STAA) STAAR Surgical Company Reports Q2 Revenue $93.5M, vs. FactSet Est of $90.6M

STAAR Surgical Company (STAA) reported its Q2 revenue of $93.5 million, surpassing FactSet's estimate of $90.6 million. This financial update indicates a positive performance for the medical equipment company during the second quarter. The article provides a brief overview of the company's recent earnings.

Insider Selling: Intuitive Surgical (NASDAQ:ISRG) Director Sells $4,000,000.00 in Stock

Intuitive Surgical director Gary Guthart sold 10,000 shares of company stock for $4 million at $400 per share under a pre-arranged Rule 10b5-1 trading plan. Despite a strong financial quarter with revenue up 18.4% and earnings beating estimates, investor concerns about slowing domestic procedure …

Intuitive Surgical director Gary Guthart sells $4m in stock

Gary S. Guthart, a director at Intuitive Surgical Inc. (NASDAQ:ISRG), sold 10,000 shares of company stock for $4 million on August 11, 2026, under a pre-arranged trading plan. Following the sale, Guthart still directly holds over 1.2 million shares, with additional shares held indirectly …

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deterioration. U.S. da Vinci procedures grew 12% in the …

Lightwave Logic (NASDAQ:LWLG) Stock Price Up 8.7% - Here's What Happened

Intuitive Surgical (ISRG) director reports 10,000-share trust sale under 10b5-1 plan

Intuitive Surgical (ISRG) director Gary S. Guthart reported an indirect sale of 10,000 common shares by a trust on August 11, 2026, at $400.00 per share, under a Rule 10b5-1 trading plan. Following the transaction, the trust holds 1,245,679 shares, with additional indirect holdings …

AbCellera Biologics (NASDAQ:ABCL) Shares Gap Down - Here's Why

GIC Housing Finance net profit falls 81% QoQ to ₹100.8 crore in Q1FY27

Intuitive Surgical's Competitors Face Challenges That Limit Long-Term Appeal, Oppenheimer Says

Intuitive Surgical's (ISRG) competitors face unique workflow challenges and real estate issues that impact their long-term appeal, while customized price-volume contracts complicate competitors' return on investment and its flexible per-click model allows growth opportunities in Silver Upgrade to read this MT Newswires article and …

AbCellera Biologics Inc. (NASDAQ:ABCL) Given Consensus Recommendation of "Moderate Buy" by Analysts

AbCellera Biologics Inc. (NASDAQ:ABCL) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $12.83, notably boosted by Truist Financial's increased target of $30. The company's shares have rallied significantly following positive Phase 2 results for its experimental …

This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Several top Wall Street analysts have updated their ratings for key companies. Mizuho upgraded IDEX Corp to Outperform, Deutsche Bank upgraded Entegris Inc to Buy, Oppenheimer upgraded Intuitive Surgical Inc to Outperform, and Citizens upgraded Okta Inc to Market Outperform, all with increased price …

Revenue Downgrade: Here's What Analysts Forecast For AbCellera Biologics Inc. (NASDAQ:ABCL)

Analysts have recently downgraded their revenue forecasts for AbCellera Biologics Inc. for 2024 and 2025, suggesting a more cautious outlook on the company's near-term growth prospects. Despite the revised estimates, the average price target for ABCL stock remains unchanged, implying that analysts see potential …

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

Key Points The robotic surgery specialist has over 12,000 installed systems globally. Right now, it's facing some headwinds, but it also has a lot going for it. The Baron Health Care Fund sees Intuitive Surgical as full of promise.10 stocks we like better than …

Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"

Investing.com -- Oppenheimer upgraded Intuitive Surgical to Outperform from Perform with a $500 price target in a note on Wednesday, arguing the company's strategy of "Crowding Out Competitors" is strategically smart. Analyst Suraj Kalia said the change reflects "a more nuanced risk-reward assessment at …

If You Invested $1000 in Intuitive Surgical, Inc. 10 Years Ago, This Is How Much You'd Have Now

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in …

QuickLogic Corporation Q2 2026 Earnings Call Summary

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson …

QuickLogic (NASDAQ:QUIK) Price Target Cut to $20.00 by Analysts at Needham & Company LLC

Intuitive Surgical upgraded at Oppenheimer on robotic surgery market growth

Oppenheimer has upgraded Intuitive Surgical (ISRG) to outperform, citing the company's strong position to benefit from the growing robotic surgery market. Despite increasing competition from companies like Johnson & Johnson (JNJ), Oppenheimer believes Intuitive Surgical will maintain its market dominance. This upgrade reflects confidence …

ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL)